"But we are so confident of the significance of this product and there are partners out there that recognize that this is going to be a very, very significant product". Alfred Mann
Al has always wanted a partner that shared his vision of the future of the product, well it appears several do. He seemed happy if not giddy, pleading for shareholders to be patient. For FDA to reiterate talks on children as they did prior with renewed interest also points to approval.
Can we assume Danbury inspection has been completed?
Also from the conference call in response to a question from Christopher James: "Actually, we do have sharing sessions in between our regulatory people and the regulatory people of those people as we believe to be say, top potential for partnerships...." That sounds like working very closely with a number of companies to me.
And yet they still don't have one and are still courting them according to Matt. If big pharma wanted this so bad they would be courting MNKD. Better yet, they would have already partnered up. Look for a partnership 6 months after approval.